| scholarly article | Q13442814 |
| P50 | author | Adam Frankel | Q43280576 |
| P2093 | author name string | Steven Clarke | |
| Tina Branscombe Miranda | |||
| Mark Miranda | |||
| P2860 | cites work | Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3 | Q22253444 |
| The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity | Q24291936 | ||
| Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha | Q24298570 | ||
| PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation | Q24310138 | ||
| The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase | Q24320461 | ||
| Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences | Q24336098 | ||
| Negative regulation of transcription by the type II arginine methyltransferase PRMT5 | Q24522638 | ||
| Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 | ||
| The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins | Q24548244 | ||
| Crystal structure of the conserved core of protein arginine methyltransferase PRMT3 | Q24631369 | ||
| A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1 | Q24652837 | ||
| Structure of the Predominant Protein Arginine Methyltransferase PRMT1 and Analysis of Its Binding to Substrate Peptides | Q27641186 | ||
| The predominant protein-arginine methyltransferase from Saccharomyces cerevisiae | Q27931102 | ||
| Automated identification of putative methyltransferases from genomic open reading frames | Q27940326 | ||
| S-Adenosylmethionine-dependent methylation in Saccharomyces cerevisiae. Identification of a novel protein arginine methyltransferase | Q27940350 | ||
| Regulation of transcription by a protein methyltransferase | Q28138085 | ||
| Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains | Q28140712 | ||
| Arginine methylation of STAT1 regulates its dephosphorylation by T cell protein tyrosine phosphatase | Q28217313 | ||
| Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice | Q28586486 | ||
| Biological significance of endogenous methylarginines that inhibit nitric oxide synthases | Q33847583 | ||
| Analysis of the yeast arginine methyltransferase Hmt1p/Rmt1p and its in vivo function. Cofactor binding and substrate interactions. | Q33888183 | ||
| Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury | Q44045935 | ||
| RNA and protein interactions modulated by protein arginine methylation. | Q46021819 | ||
| PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins | Q56227906 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | regulation of protein binding | Q14762271 |
| Protein arginine methyltransferase 7 | Q21131695 | ||
| P304 | page(s) | 22902-22907 | |
| P577 | publication date | 2004-03-24 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity | |
| P478 | volume | 279 |
| Q53606827 | 2 The family of protein arginine metkyltransferases. |
| Q86996667 | 3 Diverse roles of protein arginine methyltransferases |
| Q38683201 | 4 Structure of protein arginine methyltransferases |
| Q33851089 | A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. |
| Q46762026 | A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism |
| Q37191986 | A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation |
| Q43144597 | A type III protein arginine methyltransferase from the protozoan parasite Trypanosoma brucei |
| Q24311057 | Accurate localization and relative quantification of arginine methylation using nanoflow liquid chromatography coupled to electron transfer dissociation and orbitrap mass spectrometry |
| Q33598698 | Approaches to measuring the activities of protein arginine N-methyltransferases |
| Q34002244 | Arginine methylation in subunits of mammalian pre-mRNA cleavage factor I. |
| Q24314833 | Arginine methylation regulates DNA polymerase beta |
| Q41927743 | Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5). |
| Q39825872 | Arginine methylation regulates telomere length and stability. |
| Q28512283 | Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression |
| Q26851594 | Arginine methyltransferases as novel therapeutic targets for breast cancer |
| Q37962018 | Arginine/lysine-methyl/methyl switches: biochemical role of histone arginine methylation in transcriptional regulation |
| Q30320082 | Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src |
| Q38160040 | Autoantigens: novel forms and presentation to the immune system |
| Q39124126 | Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity. |
| Q35722457 | Chemical biology of protein arginine modifications in epigenetic regulation |
| Q37097824 | Chemical mechanisms of histone lysine and arginine modifications |
| Q62606063 | Clinical evaluation of PRMT1 gene expression in breast cancer |
| Q37618558 | Cloning, expression, purification and preliminary X-ray crystallographic analysis of mouse protein arginine methyltransferase 7. |
| Q28279298 | DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo |
| Q36380990 | Endogenous production of nitric oxide synthase inhibitors |
| Q35690493 | Expression of the epigenetic factor BORIS (CTCFL) in the human genome |
| Q24305093 | FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues |
| Q41294816 | Förster resonance energy transfer measurements of cofactor-dependent effects on protein arginine N-methyltransferase homodimerization. |
| Q35945148 | Generation of polyclonal antiserum for the detection of methylarginine proteins |
| Q57477141 | Global pentapeptide statistics are far away from expected distributions |
| Q89603924 | High Expression of CARM1 Inhibits Lung Cancer Progression by Targeting TP53 by Regulating CTNNB1 |
| Q37809211 | Histone arginine methylation |
| Q36742450 | Histone modifications and chromatin dynamics: a focus on filamentous fungi |
| Q35868191 | Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming ω-NG-monomethylated arginine residues. |
| Q89496543 | Identification and Characterization of Two New S-Adenosylmethionine-Dependent Methyltransferase Encoding Genes Suggested Their Involvement in Stipe Elongation of Flammulina velutipes |
| Q37271887 | Identification of genomic regions contributing to etoposide-induced cytotoxicity |
| Q104495202 | Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues |
| Q34456824 | Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1. |
| Q38908624 | Identification of the PRMT1v1 and PRMT1v2 specific interactomes by quantitative mass spectrometry in breast cancer cells. |
| Q22330787 | Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression |
| Q38460893 | Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6). |
| Q37415617 | Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions |
| Q24558697 | Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression |
| Q35569422 | Methylation of eukaryotic elongation factor 2 induced by basic fibroblast growth factor via mitogen-activated protein kinase |
| Q51958231 | Nuclear proteome analysis of undifferentiated mouse embryonic stem and germ cells. |
| Q45989245 | Oxidative Modifications in Tissue Pathology and Autoimmune Disease. |
| Q30008797 | PRMT2 interacts with splicing factors and regulates the alternative splicing of BCL-X. |
| Q89640752 | PRMT5 in gene regulation and hematologic malignancies |
| Q24684168 | PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA |
| Q24303480 | PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation |
| Q91891426 | PRMT7 as a unique member of the protein arginine methyltransferase family: A review |
| Q24307732 | PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine |
| Q24310851 | PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family |
| Q94686440 | Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response |
| Q38390268 | Prmt7 is dispensable in tissue culture models for adipogenic differentiation |
| Q38064312 | Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders. |
| Q39996364 | Protein arginine (N)-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins |
| Q29617309 | Protein arginine methylation in mammals: who, what, and why |
| Q35191784 | Protein arginine methylation in parasitic protozoa |
| Q38168045 | Protein arginine methylation of non-histone proteins and its role in diseases |
| Q24322755 | Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a |
| Q27690032 | Protein arginine methyltransferase 7 has a novel homodimer-like structure formed by tandem repeats |
| Q35550160 | Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression |
| Q28270318 | Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase δ catalytic subunit gene, POLD1 |
| Q38012526 | Protein arginine methyltransferases (PRMTs) as therapeutic targets |
| Q37726342 | Protein arginine methyltransferases: nuclear receptor coregulators and beyond |
| Q36043261 | Protein interfaces in signaling regulated by arginine methylation |
| Q34752160 | Protein-arginine methyltransferase 1 (PRMT1) methylates Ash2L, a shared component of mammalian histone H3K4 methyltransferase complexes |
| Q88749962 | Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy |
| Q34699830 | Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain |
| Q24306650 | Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3) |
| Q41864190 | RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity. |
| Q38219647 | Role of PRMTs in cancer: Could minor isoforms be leaving a mark? |
| Q91565531 | Roles and regulation of histone methylation in animal development |
| Q26825534 | Structural and functional coordination of DNA and histone methylation |
| Q36115471 | Structural and sequence motifs of protein (histone) methylation enzymes |
| Q27695578 | Structural insight into arginine methylation by the mouse protein arginine methyltransferase 7: a zinc finger freezes the mimic of the dimeric state into a single active site |
| Q30008818 | Structural studies of protein arginine methyltransferase 2 reveal its interactions with potential substrates and inhibitors |
| Q34552608 | Substrate specificity of human protein arginine methyltransferase 7 (PRMT7): the importance of acidic residues in the double E loop |
| Q37941687 | Targets in epigenetics: inhibiting the methyl writers of the histone code |
| Q33983096 | TbPRMT6 is a type I protein arginine methyltransferase that contributes to cytokinesis in Trypanosoma brucei |
| Q24295612 | The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6 |
| Q38725177 | The Major Protein Arginine Methyltransferase in Trypanosoma brucei Functions as an Enzyme-Prozyme Complex. |
| Q43223801 | The PRMT1 gene expression pattern in colon cancer |
| Q37419015 | The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans |
| Q21146034 | The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation |
| Q24313636 | Toward an assembly line for U7 snRNPs: interactions of U7-specific Lsm proteins with PRMT5 and SMN complexes |
| Q29871503 | Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2 |
| Q35369909 | Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1). |
Search more.